Drug
Atazanavir clinical trials
Also written Reyataz and BMS-232632.
- studies test it
- 109
- open now
- 1
- in phase 3
- 28
- first study started
- 2001
Keep track of what changes. Save the atazanavir studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
- Reyataz
- 39
Development codes
Studies by the year they started
108 studies that test it; most in 2006 (14)
| Year | Studies |
|---|---|
| 2001 | 3 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 9 |
| 2005 | 13 |
| 2006 | 14 |
| 2007 | 8 |
| 2008 | 5 |
| 2009 | 14 |
| 2010 | 3 |
| 2011 | 9 |
| 2012 | 7 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 5 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 31
- Phase 2
- 15
- Phase 3
- 28
- Phase 4
- 34
- No phase
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 55 · Other 54
Bristol-Myers Squibb (35) · Gilead Sciences (8) · National Institute of Allergy and Infectious Diseases (NIAID) (4) · Radboud University Medical Center (4) · ViiV Healthcare (3) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (3) · ANRS, Emerging Infectious Diseases (2) · French National Agency for Research on AIDS and Viral Hepatitis (2)
Often tested with
Tested in the same studies.
Ritonavir (49) · Tenofovir (11) · Darunavir (10) · Cobicistat (9) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (9) · Emtricitabine (8) · Efavirenz (8) · Raltegravir (7)
Studies
Open first, then newest update. How each study uses atazanavir is read from its arms, and is right about nine times in ten.
Testing it · 109
- A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV TreatmentsRecruitingPhase 4Gilead SciencesNCT06337032Written as ATV
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIVActive, not recruitingPhase 2/3Gilead SciencesNCT02016924Written as ATV
- Early and Intermittent Antiretroviral Therapy in Naive HIV Infected AdultsCompletedPhase 2ANRS, Emerging Infectious DiseasesNCT00820118Written as Structured treatment interruption
- Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and TruvadaCompletedPhase 2French National Agency for Research on AIDS and Viral HepatitisNCT00528060Written as Atazanavir
- Antiviral Agents Against COVID-19 InfectionCompletedPhase 2/3Hospital do CoracaoNCT04468087Written as Atazanavir
- A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable ViremiaCompletedPhase 2Castagna AntonellaNCT02542852Written as atazanavir 300 mg + ritonavir 100 mg + dolutegravir 50 mg
- Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI BackboneWithdrawnPhase 3Bristol-Myers SquibbNCT01605084Written as Atazanavir
- A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriate Mini-Tablet Formulations and the Coadministration of the Individual Reference Products in Healthy Adults Under Fed ConditionsCompletedPhase 1Bristol-Myers SquibbNCT05236738Written as Atazanavir
- The Nitazoxanide Plus Atazanavir for COVID-19 StudyTerminatedPhase 2Obafemi Awolowo UniversityNCT04459286Written as Nitazoxanide and atazanavir/ritonavir
- Taste Properties of Atazanavir and CobicistatCompletedPhase 1Bristol-Myers SquibbNCT02307656Written as Atazanavir
- Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected ChildrenCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00260078Written as Atazanavir
- Preventing Sexual Transmission of HIV With Anti-HIV DrugsCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00074581Written as Atazanavir
- Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected AdultsCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00096850Written as Atazanavir
- Atazanavir/Ritonavir Maintenance TherapyCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00084019Written as Atazanavir
- Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected AdultsCompletedPhase 3Gilead SciencesNCT02603107Written as ATV
- A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/CobicistatCompletedPhase 1Radboud University Medical CenterNCT02565888Written as Atazanavir
- Pharmacokinetics of Atazanavir /Dolutegravir/Lamivudine Regimen as Maintenance RegimenTerminatedPhase 2Radboud University Medical CenterNCT02566707Written as Atazanavir
- Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected PatientsCompletedPhase 2Radboud University Medical CenterNCT00943540Written as atazanavir
- Pharmacokinetics of Maraviroc and Boosted Atazanavir Dual Regimen in Stable HIV-infected PatientsWithdrawnPhase 3University of Turin, ItalyNCT03708861Written as maraviroc (300 mg QD) + atazanavir/ritonavir (300 and 200 mg /100 mg QD)
- Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected PatientsCompletedPhase 1/2The HIV Netherlands Australia Thailand Research CollaborationNCT00411957Written as Atazanavir
See all 109 studies that test atazanavir →
Given in every arm · 14 — atazanavir is usual care beside what is tested
- Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TCTerminatedPhase 3Bristol-Myers SquibbNCT01620944Written as Atazanavir
- Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat TrialsCompletedPhase 1Acrotech Biopharma Inc.NCT04184869Written as Atazanavir
- Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and AdolescentsCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00006604Written as ATV
- Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric PatientsCompletedPhase 3Bristol-Myers SquibbNCT01335698Written as Atazanavir Sulphate
- Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced AdultsTerminatedPhase 2ViiV HealthcareNCT02386098Written as Atazanavir (ATV)
- RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected PatientsStatus unknownPhase 4Pedro CahnNCT01829802Written as Ritonavir boosted Atazanavir
- Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive AdultsCompletedPhase 3Gilead SciencesNCT01108510Written as ATV
- Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive AdultsCompletedPhase 2Gilead SciencesNCT00892437Written as ATV
- Pilot Study of a Raltegravir Based NRTI Sparing RegimenCompletedNot applicableYale UniversityNCT00814879Written as Atazanavir
- PK TDF in Thai HIV-infected ChildrenCompletedNot applicableThe HIV Netherlands Australia Thailand Research CollaborationNCT02404259Written as lopinavir/ritonavir, atazanavir/ritonavir
- Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected PatientsCompletedPhase 4Bristol-Myers SquibbNCT01332227Written as Atazanavir
- Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02257008Written as Atazanavir
- Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.CompletedPhase 1/2Gilead SciencesNCT01565889Written as ATV
- Phase IIB Pilot of Atazanavir + RaltegravirTerminatedPhase 2Bristol-Myers SquibbNCT00768989Written as Atazanavir
As the comparator · 8 — what is tested is compared with atazanavir
- A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)CompletedPhase 3ViiV HealthcareNCT01910402Written as Atazanavir
- NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 InfectionStatus unknownPhase 2/3Biomed Industries, Inc.NCT04452565Written as NA-831 and Atazanavir
- Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive ParticipantsCompletedPhase 3Gilead SciencesNCT01815736Written as ATV
- Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected WomenCompletedPhase 3Gilead SciencesNCT02652624Written as ATV
- Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)TerminatedPhase 2Merck Sharp & Dohme LLCNCT02116660Written as Atazanavir
- HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) InfectionsCompletedPhase 2ViiV HealthcareNCT01384734Written as Atazanavir 300 mg
- Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsCompletedPhase 3Gilead SciencesNCT01106586Written as ATV
- Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive AdultsCompletedPhase 3Boehringer IngelheimNCT00389207Written as atazanavir
Codes
What other systems call atazanavir · ClinicalTrials.gg INT006580
- MeSH (NLM) D000069446Atazanavir SulfateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) QZU4H47A3SATAZANAVIRConfirmed FDA, NLM, Wikidata
- RxNorm 343047Confirmed FDA, Wikidata
- Wikidata Q423467atazanavirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66872AtazanavirOne source FDA
- DrugBank DB01072One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069446 | Atazanavir Sulfate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | QZU4H47A3S | ATAZANAVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 343047 | — | Confirmed FDA, Wikidata |
| Wikidata | Q423467 | atazanavir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66872 | Atazanavir | One source FDA |
| DrugBank | DB01072 | — | One source Wikidata |
Also registered as atazanavir sulfate (UNII 4MT4VIE29P · RxNorm 358299).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.